NIHR Maudsley Biomedical Research Centre

What NIHR Maudsley Biomedical Research Centre does

NIHR Maudsley Biomedical Research Centre (BRC) is a publicly funded translational research centre established in 2007 and hosted by South London and Maudsley NHS Foundation Trust in partnership with King's College London's Institute of Psychiatry, Psychology & Neuroscience (IoPPN). It operates as part of the UK National Institute for Health and Care Research (NIHR) infrastructure and is a founding co-lead (with NIHR Oxford Health BRC) of the NIHR Mental Health Translational Research Collaboration. The centre organises its work across 10 research themes spanning brain and mental health conditions (psychosis and mood disorders, eating disorders and obesity, child and neurodevelopmental disorders, motor neuron disease, pain and addictions) and methods/technologies (digital therapies, informatics, neuroimaging, experimental medicine, trials and genomics). Funding flows primarily from NIHR grants, the Wellcome Trust, the Medical Research Council, NHS England and charitable partners; no commercial pricing model is operated at the parent entity level.

The centre's underlying technology stack is an AI-powered clinical informatics platform that combines natural language processing, machine learning and electronic health record analysis for mental health research and clinical decision support. Core proprietary assets include CogStack (an NLP-based information retrieval and extraction platform deployed across 11 NHS trusts and 3 Sub-National Safe Data Environments, generating 1 billion+ SNOMED-CT annotations), Foresight (a GPT-based deep-learning pipeline that forecasts future disorders, symptoms, medications and interventions, trained on EHRs from 811,000+ patients and published in The Lancet Digital Health), RADAR-Base (open-source wearable/smartphone data collection), the CRIS clinical record interactive search system, and MedCAT for clinical concept annotation. Translational digital therapies developed or co-developed at the centre include AVATAR Therapy and SloMo (both NICE-EVA recommended for psychosis), IMPARTS (integrating mental/physical health screening across 75 services, 102,546+ patient visits), myHealthE (child and adolescent mental health PROMs integrated with NHS records, 1,300+ families enrolled), COMPASS/Orbi (CE-marked digital CBT for anxiety and depression in long-term conditions) and REFUEL-MS (smartphone MS fatigue management).

Commercially, the BRC historically operated as a non-commercial research infrastructure. In December 2025 it formally launched CogStack as a university spinout from King's College London, NIHR Maudsley BRC and UCLH BRC, with explicit plans to scale revenue through automated clinical coding and life-sciences partnerships, representing the centre's first material move into commercial product distribution. Distribution of research outputs and digital therapies otherwise occurs through NHS clinical settings, the NIHR infrastructure network, multi-site NHS trials, and open-source releases (e.g., CogStack, RADAR-Base, MedCAT). Primary customer/counterparty segments are NHS Trusts (vertical-internal), people with mental health conditions, academic researchers, and — increasingly — pharma/biotech partners engaging on trials, biomarker discovery and digital health development.

Name

NIHR Maudsley Biomedical Research Centre

Legal name

NIHR Maudsley Biomedical Research Centre (BRC)

Website

https://maudsleybrc.nihr.ac.uk

Company type

Private

Founded year

2007

Operating status

Operating

Headcount range

51–100 employees

Short description

NIHR Maudsley Biomedical Research Centre is a UK publicly funded mental health research centre, hosted by South London and Maudsley NHS Foundation Trust with King's College London, that develops AI-powered clinical informatics (CogStack, Foresight) and digital therapies (AVATAR, SloMo, IMPARTS, myHealthE) for NHS patients and translational research.

Ownership category

akta.pro rank

Product category

Mental Health Research and Biomedical Innovation

NAICS

Scientific Research and Development Services (5417), Research and Development in Biotechnology (except Nanobiotechnology) (541714)

SIC

Services-Commercial Physical & Biological Research (8731), Services-Prepackaged Software (7372)

akta.pro primary industry

Scientific Data Management & Data Platforms (SDMS/Data Lakehouse for R&D) (HLAGAJAC)

akta.pro secondary industries

Clinical Trial Informatics (EDC/CTMS/eCOA/eTMF) (HLAGAJAM), AI/ML Platforms for Drug Discovery & Experiment Optimization (HLAGAJAO), General Mental Health Therapy Platforms (Talk Therapy) (HLALAEAA)

Keywords

• Mental health research
• Biomedical research
• Digital therapeutics
• Clinical informatics
• Health data analytics

Headquarters

HQ city

London

HQ country

United Kingdom

HQ region

Europe

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Technology or R&D, Operations, Infrastructure

Distribution channels4 records

Marketing channels9 records

Core offering

NIHR Maudsley Biomedical Research Centre brings together clinicians, researchers and people with lived experience to transform scientific discoveries into new treatments, diagnostics and technologies for brain and mental health. Its core offerings include AI-powered clinical informatics platforms (CogStack, Foresight, RADAR-Base), evidence-based digital therapies (AVATAR Therapy, SloMo, COMPASS, REFUEL-MS), and large-scale genetics research cohorts (GLAD Study, EDGI UK), supported by world-class infrastructure and NHS clinical integration.

Product overview

NIHR Maudsley Biomedical Research Centre operates as a research infrastructure hub that has developed multiple distinct digital health products and platforms. The portfolio includes: CogStack (NLP platform for EHR data extraction, now a university spinout) and Foresight (GPT-based AI prediction tool) as core informatics platforms; AVATAR Therapy and SloMo as NICE-recommended digital therapies for psychosis; IMPARTS and myHealthE for integrating mental health into physical health and child mental health services respectively; COMPASS/Orbi and REFUEL-MS as condition-specific digital therapies for long-term conditions and MS; RADAR-Base for wearable data collection; and the GLAD Study/EDGI UK as major genetics research initiatives. These products range from commercialised digital therapies to open-source research tools and large-scale research cohorts, unified by the BRC's mental health research mission.

Differentiator

Problem solved

Functional benefit

Products and services

• CogStack NLP-based information retrieval and extraction platform that unlocks data from electronic health records using AI and natural language processing. Deployed in 11 NHS trusts and 3 Sub-National Safe Data Environments, processing both structured and unstructured data including over 1 billion+ SNOMED annotations. Freely accessible open-source platform with commercial spinout.
• AVATAR Therapy Digital therapy using computerised avatars to represent distressing voices in psychosis. Involves a 'trialogue' between therapist, patient and avatar across exposure/anxiety reduction and personalised therapeutic targets phases. NICE-EVA recommended for NHS use and tested in multi-site RCT with 8 NHS Trusts and 345 participants.
• SloMo Inclusive digitally-supported therapy for managing distressing thoughts or paranoia. First evidence-based, UKCA-marked digital therapeutic for treating paranoia. Visualises thoughts as bubbles to help manage worries. NICE-EVA recommended for NHS use.
• IMPARTS Integrating Mental and Physical Healthcare: Research, Training and Services platform. Digital questionnaire integrates mental health screening into physical health appointments. Used in 75 services across two hospital trusts, assisting 102,546+ patient visits, with responses uploaded directly to electronic health records.
• myHealthE Digital service integrating patient-reported outcome measures with NHS electronic records for child and adolescent mental health. Achieved 12-fold increase in PROM completion. Includes virtual waiting room functionality for CAMHS services, with agreements at 12 NHS and local authority sites and 1,300+ families enrolled.
• COMPASS (now Orbi) Therapist-guided digital cognitive behavioural therapy programme for managing anxiety and depression in people with long-term physical health conditions. CE-marked. 89% of participants showed clinically significant improvement in distress.
• REFUEL-MS Smartphone app for managing Multiple Sclerosis fatigue symptoms. Delivers CBT, graded physical activity and balance exercises. Developed in partnership with Avegen. Selected for UK Government's Innovative Devices Access Pathway (IDAP) pilot scheme.
• RADAR-Base Open-source platform collecting patient-generated data from wearables and smartphones. Award-winning platform used globally across physical and mental health conditions. Developed by NIHR Maudsley BRC informatics team.
• GLAD Study Genetic Links to Anxiety and Depression - largest UK study collecting psychological, medical and genetic data. 47,000+ participants enrolled. Part of NIHR BioResource for Mental Health. Used to identify 74 genetic loci linked to anxiety symptoms in a study of 693,868 people.
• Foresight GPT-based AI pipeline that forecasts future medical events (disorders, symptoms, medications, interventions) from electronic health records. Part of CogStack ecosystem. Trained on 811,000+ patients across NHS trusts and US MIMIC-III dataset, with 68-88% accuracy for predicting next 10 disorders and 80-91% precision for biomedical concepts.

Segments4 records

Ideal customer profiles3 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Integration2 records

AI capability8 records

Feature6 records

Partnerships

20 partnerships are on record, tiered core and major.

• South London and Maudsley NHS Foundation TrustcoreStrategic or Co-development PartnerCore NHS partner hosting the BRC. Provides clinical settings for research, patient access for trials, and governance for data infrastructure including CRIS platform and CogStack deployment. Long-standing partnership since 2009.
• King's College LondoncoreStrategic or Co-development PartnerAcademic host institution providing research expertise, facilities, and academic infrastructure. Partnership through Institute of Psychiatry, Psychology & Neuroscience (IoPPN).
• University College London Hospitals BRCcoreTechnology or IntegrationCo-developed CogStack platform with UCLH BRC. Collaboration on NLP and AI solutions for electronic health records. Shared deployment and development.
• NIHR Oxford Health BRCcoreStrategic or Co-development PartnerCo-founded and co-lead the NIHR Mental Health Translational Research Collaboration (MH-TRC). Partnership for UK-wide mental health research coordination.
• NIHR Applied Research Collaboratives (ARCs)majorStrategic or Co-development PartnerCollaboration on trial recruitment acceleration and mental health research initiatives through NIHR infrastructure network.
• NHS AI LabmajorStrategic or Co-development PartnerPartnership for AI development in healthcare including Foresight project funding and AI fairness innovation initiatives.
• MindmajorStrategic or Co-development PartnerCharitable partner for GLAD Study recruitment and design. One of several mental health charities including MQ Mental Health Research, British Psychological Society, Royal College of Psychiatrists, Anxiety UK, LGBT-HERO, Rethink Mental Illness.
• King's College Hospital NHS Foundation TrustcoreStrategic or Co-development PartnerNHS partner for CogStack deployment and Foresight AI development. Collaborates on clinical informatics and AI early warning systems.
• Guy's and St Thomas' NHS Foundation TrustcoreStrategic or Co-development PartnerNHS partner for CogStack deployment. IMPARTS platform deployed across this trust. Collaborates on Foresight AI development.
• Health Data Research UK (HDR UK)majorStrategic or Co-development PartnerPartnership for national data infrastructure including Foresight-SDE project for 51 million people through NHS England, Databricks, AWS partnership.
• Monash Partners Academic Health Science CentremajorTechnology or IntegrationInternational partner who deployed CogStack receiving AUS$1.92 million funding for local deployment. Extends CogStack reach internationally.
• Amazon Web ServicesmajorTechnology or IntegrationTechnology partner for Foresight-SDE national foundation model development for 51 million people through NHS England partnership.
• DatabricksmajorTechnology or IntegrationTechnology partner for Foresight-SDE national foundation model development through NHS England partnership.
• NIHR Manchester BRCmajorStrategic or Co-development PartnerCollaborated on AVATAR2 multi-site trial and supported therapy delivery through NIHR King's Clinical Research Facility.
• UCL (University College London)coreStrategic or Co-development PartnerCo-developed CogStack platform. AVATAR therapy developed in partnership with UCL.
• AvegenmajorStrategic or Co-development PartnerDigital health solutions company developing REFUEL-MS app for MS fatigue and COMPASS digital therapy. Commercial partnership for app development and deployment.
• NIHR King's Clinical Research FacilitycoreStrategic or Co-development PartnerNIHR infrastructure providing clinical research facility for AVATAR therapy delivery and trials.
• King's Health PartnerscoreStrategic or Co-development PartnerAcademic Health Science Centre partnership enabling integrated research and clinical care across King's College London and NHS partners.
• Broad InstitutemajorStrategic or Co-development PartnerCollaboration with Broad Institute of MIT and Harvard for exome sequencing of EDGI UK eating disorders participants using Blended Exome Genome strategy.
• NIHR BioResourcecoreStrategic or Co-development PartnerPartnership for BioResource for Mental Health enabling genetic studies and participant recruitment across mental health conditions.

Scale indicators10 records

Recent moves7 records

Expansion highlights5 records

Emerging players

• Flatiron Health: Health technology company that structures and analyzes real-world clinical data from EHRs to accelerate cancer research and drug development, comparable in applying NLP and AI to clinical records for research and life sciences partnerships.
• Tempus AI: AI-powered precision medicine company that combines clinical and molecular data at scale, comparable to Foresight's approach of building predictive models on integrated EHR data for clinical decision support and trial optimization.
• Owkin: AI-for-healthcare research platform that uses federated learning and AI on clinical and biomedical data, comparable in its focus on applying AI to clinical datasets for drug discovery and clinical research, with overlapping pharma partnership model.

Broad incumbents

• Verily Life Sciences: Alphabet's life sciences and healthcare subsidiary operating large-scale clinical research platforms, real-world evidence generation, and AI health tools, overlapping with CogStack's and Foresight's clinical AI and translational research mandate.
• King's College London (IoPPN): Academic host institution for NIHR Maudsley BRC through the Institute of Psychiatry, Psychology & Neuroscience, providing the world's largest centre of its kind for mental health research, with overlapping research themes, faculty, and translational programs.
• Health Data Research UK: National partnership for UK health data infrastructure including the Foresight-SDE project, operating as a UK-wide institute for health data science with overlapping mandate to enable research using large-scale clinical datasets.

Direct peers

• Genomics England: UK government-backed genomics initiative running large-scale population cohort studies and clinical genomics at national scale, directly comparable to the BRC's GLAD Study and EDGI UK genetic research initiatives.
• NIHR Oxford Health Biomedical Research Centre: Co-founder and co-lead of the NIHR Mental Health Translational Research Collaboration with NIHR Maudsley BRC since 2017, operating an identical NIHR BRC model focused on mental health and dementia research with NHS Trust and University of Oxford partnership.
• University College London Hospitals Biomedical Research Centre: Co-developer of the CogStack platform with NIHR Maudsley BRC, sharing NLP and AI solutions for electronic health records. Operates a comparable NIHR BRC model with strong focus on clinical informatics and hospital-based translational research.

Regional players

• Monash Partners Academic Health Science Centre: International partner that deployed CogStack with AUS$1.92M funding, applying the same AI clinical informatics platform in Australia. Operates a comparable academic health science centre model for translational research.

Market position

Strengths5 records

Weaknesses4 records

Competitive moat5 records

Key risks6 records

Key highlights7 records

Customer concentration

• Xx.com/NIHRMaudsleyBRC
• YouTubeyoutube.com/channel/UCOtl17PimB2u4auoUO-8Wqg
• Facebookfacebook.com/NIHRMaudsleyBRC
• LinkedInuk.linkedin.com/company/nihrmaudsleybrc

Revenue estimate

Valuation estimate

Number of profiles

Profiles12 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about NIHR Maudsley Biomedical Research Centre